Home » Featured » Page 21
Featured
Five senators, led by U.S. Sen. Gary Peters (D-MI), are urging Senate leadership to support additional funding for Department of Homeland Security (DHS) efforts to boost security at U.S. ports of entry and improve its ability to detect and seize drugs.
Peters, chairman of the Homeland Security... Read More »
The beginnings of the COVID-19 pandemic were a fraught time for the medical supply chain, but a new report from the U.S. Department of Health and Human Services (HHS) notes that significant gains were made by the United States health supply chain and industrial base over the last year.
“The... Read More »
Three men pleaded guilty this week after seeking to provide material support to domestic terrorists in an attempt to destroy energy facilities throughout the United States.
These charges were handed out to Christopher Brenner Cook, 20, of Columbus, Ohio; Jonathan Allen Frost, 24, of West... Read More »
Following an endorsement from the independent Data and Safety Monitoring Board this week, Moderna, Inc. officially began the third phase of trials for its mRNA Respiratory Syncytial Virus (RSC) vaccine candidate this week.
The safety greenlight was based on preliminary Phase 2 safety and... Read More »
Seeking to close a gap separating state, county, and municipal firefighters from federal firefighters, the Federal Firefighter Fairness Act of 2021 (HR 2499) is a bipartisan push to grant access to federal, job-related disability and retirement benefits for injuries and diseases contracted in the... Read More »
Seven senators last week urged the Biden administration to outline plans to develop more durable COVID-19 vaccines following a year of emerging variants that have tested the efficacy of current treatments.
Led by U.S. Sen. Tim Kaine (D-VA), a member of the Senate Health, Education, Labor, and... Read More »
With worries of a Russian incursion into Ukraine ongoing, U.S. Reps. Marc Veasey (D-TX), Raja Krishnamoorthi (D-IL), and Mike Turner (R-OH) today introduce the Supplying Ukraine with Provisions to Protect against Ongoing Russian Threats (SUPPORT) Act to guarantee support to the latter.
For the... Read More »
Lessons from one disaster can provide insights into the next and maybe even help prevent them – an idea carried forward in a new paper on COVID-19 commissioned by the Nuclear Threat Initiative (NTI) and written by retired Major Gen. Julie Bentz.
In the paper, Bentz – a former major general... Read More »
The United States Food and Drug Administration (FDA) granted breakthrough therapy designation to a Bavarian Nordic A/S vaccine candidate known as MVA-BN RSV this week, setting the preventative for RSV up for a hastened review and development cycle.
The vaccine’s focus, known as respiratory... Read More »
While monoclonal antibodies have made headway in some countries more than others, the World Health Organization (WHO), for the first time last week, offered prequalification to Roche’s tocilizumab treatment, smoothing the path to more widespread approval.
Prequalification guarantees that the... Read More »
With the Omicron variant of SARS-CoV-2 now dominating the pandemic’s reach, the U.S. Department of Health and Human Services (HHS) has sought ways to halt its effects, and as part of this effort, last week purchased 600,000 courses of a new monoclonal antibody.
This antibody, known as... Read More »
Years into a global pandemic, the Access to COVID-19 Tools (ACT) Accelerator and affiliated world leaders have called for fair, shared-based financing of approximately $23 billion in 2022 to overcome inequalities in medical access, scale-up countermeasure efforts, and end the COVID-19... Read More »
This week, U.S. Sens. Rob Portman (R-OH) and Gary Peters (D-MI) introduced a legislative package known as the Strengthening American Cybersecurity Act that proposes new requirements for private owners and federal agencies alike to address cybersecurity.
“It is clear that, as our nation... Read More »
According to the latest National Terrorism Advisory System (NTAS) Bulletin from the U.S. Department of Homeland Security (DHS), threat levels throughout the country remain heightened due to mis-, dis-, and mal-information, stoked by foreign and domestic sources.
While much focus has been paid to... Read More »
The America COMPETES Act (H.R. 4521) from U.S. Reps. Diana DeGette (D-CO) and Elissa Slotkin (D-MI), advanced last week by the House, proposes increased domestic competitiveness and oversight through greater maintenance and inspection of the Strategic National Stockpile (SNS).
“If there’s... Read More »
A combined legislative effort from U.S. Sens. Marco Rubio (R-FL) and Chris Coons (D-DE) brought the Agility in Manufacturing Preparedness Act (S.3553) to the Senate this week, offering a proposal of how to improve domestic biopharmaceutical manufacturing capabilities for public health... Read More »
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) released a new Pandemic Preparedness Plan this week, directing its research efforts toward identifying pathogens with potential for significant spread among humans and those already known to be major threats.
Informed by a... Read More »
In introducing the Active Shooter Alert Act (H.R.6538) to the House this week, U.S. Reps. David Cicilline (D-RI) and Fred Upton (R-MI) proposed creating a system similar to the AMBER Alert system for law enforcement to use in notifying the public of active, local gun violence.
AMBER Alerts are... Read More »
With the introduction of the Tracking Pathogens Act (S. 3534) this week, U.S. Sens. Tammy Baldwin (D-WI) and Bill Cassidy (R-LA) proposed the institution of national genomic sequence-based surveillance as a means of charting circulating pathogens, transmission patterns, and... Read More »
In a letter written to the U.S. Office of Science and Technology Policy (OSTP) and the National Science Foundation (NSF), a bipartisan collection of senators and representatives last week urged continued pursuit of artificial intelligence development, albeit with special care to ethics and... Read More »
Results of a multinational, Phase 3 National Institute of Allergy and Infectious Diseases (NIAID)-funded trial last week showed that combining remdesivir with anti-coronavirus hyperimmune intravenous immunoglobulin (HIVIG) fails to do more for COVID-19 hospitalized adults than remdesivir... Read More »
The Federal Trade Commission (FTC) announced a lawsuit to block Lockheed Martin Corporation from the vertical acquisition of Aerojet Rocketdyne Holdings Inc to prevent critical market consolidation.
Regulators argued the $4.4 billion acquisition effort would remove the last independent U.S.... Read More »
Drawing from a $200 million program meant to stimulate the development of vaccines with broad betacoronavirus protection, the Coalition for Epidemic Preparedness Innovations (CEPI) announced a $16.9 million award this week for development efforts by BioNet.
BioNet, a French-Thai vaccine... Read More »
In a move that prompted backlash from Florida in particular, the United States Food and Drug Administration (FDA) this week announced revised and restricted authorizations of bamlanivimab/etesevimab and REGEN-COV for COVID-19 treatment.
While the two had been available before this, Dr. Patrizia... Read More »
Formerly only used for patients hospitalized with COVID-19, the Gilead Sciences Inc. drug veklury – also known as remdesivir – was expanded by order of the U.S. Food and Drug Administration (FDA) last week to include treatment for mild to moderate cases as well.
Both non-hospitalized adults... Read More »
Backed by various law enforcement organizations and bipartisan appeal, U.S. Reps. Josh Gottheimer (D-NJ) and John Rutherford (R-FL) – together with 36 cosponsors – introduced the Invest to Protect Act of 2022 last week to support local police.
The House bill seeks critical investments into... Read More »
The Coalition for Epidemic Preparedness Innovations’ (CEPI) 100 Days Mission to reduce the vaccine development timeline received a $300 million investment from the Bill & Melinda Gates Foundation and Wellcome.
While a fraction of the organization’s overall fundraising goal of $3.5 billion,... Read More »
A new partnership between governmental, military, and academic scientists seeks to collaboratively develop a vaccine over the next five years capable of protecting against tularemia, melioidosis, and plague from a single source.
Aided by a $10 million grant for the Defense Threat Reduction... Read More »
In the latest effort to get ahead of future medical equipment shortages, U.S. Rep. Josh Gottheimer (D-NJ) announced plans for the Medical and Health Stockpile Accountability Act last week, proposing a new tracking system and data sharing guidelines, and more.
While building greater resilience... Read More »
Following requests from U.S. authorities, the Russian Federal Security Service (FSB) arrested members of the REvil ransomware gang and shut their operations, which in the last few years have struck American ventures such as the Colonial Pipeline, JBS Foods, and Kaseya.
The Russian-based group... Read More »
With the introduction of the House version of the Strengthening Supply Chains for Servicemembers and Security Act (H.R. 6374), U.S. Reps. Chrissy Houlahan (D-PA) and Peter Meier (R-MI) this week sought to bolster cut overreliance on foreign pharmaceuticals and strengthen the domestic supply... Read More »
U.S. Sens. Richard Burr (R-NC) and John Hickenlooper (D-CO) this week introduced a bipartisan bill that would increase the National Institutes of Health’s (NIH) collaboration efforts surrounding research and development of countermeasures for pathogens with pandemic potential.
“Two years... Read More »
In response to the Chinese government's refusal to allow a comprehensive investigation into the origins of COVID-19, a collection of Republican senators introduced the Coronavirus Origin Validation, Investigation and Determination (COVID) Act this week.
The bill seeks to authorize sanctions... Read More »
According to GlaxoSmithKline plc (GSK) and Vir Biotechnology, Inc., the United States government this week agreed to purchase another 600,000 doses of the COVID-19 antibody treatment sotrovimab, which will be distributed in this first quarter of 2022.
The arrangement stems from an amendment to... Read More »
U.S. Sen. Kirsten Gillibrand (D-NY) joined U.S. Reps. Brian Higgins (D-NY) and Chris Jacobs (R-NY) in urging the U.S. Department of Homeland Security to keep the U.S.-Canada border open for vaccinated individuals.
Citing the economic livelihoods of New York businesses, as well as supply chain... Read More »
